Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Re-irradiation in Recurrent and Second Primary Head and Neck Cancer”

6 trials

Showing 6 of 6 results

Not applicableStudy completedNCT01427010
What this trial is testing

A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.

Who this might be right for
Re-irradiation in Recurrent and Second Primary Head and Neck Cancer
University Hospital, Ghent 10
Testing effectiveness (Phase 2)Ended earlyNCT04220775
What this trial is testing

Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaSecond Primary Squamous Cell Carcinoma of the Head and Neck
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03521570
What this trial is testing

Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Emory University 62
Testing effectiveness (Phase 2)UnknownNCT00004226
What this trial is testing

Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy

Who this might be right for
Head and Neck Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT02289209
What this trial is testing

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
Dan Zandberg 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03546582
What this trial is testing

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
RTOG Foundation, Inc. 86

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation